FBT holdings and overlap
First Trust NYSE Arca Biotechnology Index Fund (FBT) holds 30 positions in its SEC Form N-PORT for the period ended 2026-06-30, filed 2026-08-21. Its three largest are Corcept Therapeutics (CORT) at 5.60%, NeoGenomics (NEO) at 5.12% and Veracyte (VCYT) at 5.10%, and its ten largest make up 43.2% of the fund.
In its SEC Form N-PORT for the period ended 2026-06-30, filed 2026-08-21, FBT is 100.0% health care by sector, with none of it in mega-cap tech or in the ten largest US companies by market value. By country, 91.6% of FBT is in the United States, 3.1% in Belgium, 2.6% in Germany and 2.6% in Denmark.
What does FBT hold, from its SEC Form N-PORT for the period ended 2026-06-30?
FBT spreads its weight across 30 positions, against a median of 61 across the 28 Health Care funds with a page here. The position FBT carries furthest above that group is NeoGenomics at 5.12% of the fund, a company the median fund in that group does not hold at all.
| Rank | Company | Weight | Weight bar |
|---|---|---|---|
| 1 | CORT Corcept Therapeutics | 5.6% | |
| 2 | NEO NeoGenomics | 5.12% | |
| 3 | VCYT Veracyte | 5.1% | |
| 4 | BRKR Bruker | 4.32% | |
| 5 | ALKS Alkermes | 4.24% | |
| 6 | ILMN Illumina | 3.92% | |
| 7 | KRYS Krystal Biotech | 3.87% | |
| 8 | NTRA Natera | 3.79% | |
| 9 | AXSM Axsome Therapeutics | 3.71% | |
| 10 | NBIX Neurocrine Biosciences | 3.53% | |
| 11 | TECH Bio-Techne | 3.43% | |
| 12 | ARWR Arrowhead Pharmaceuticals | 3.38% | |
| 13 | BIIB Biogen | 3.37% | |
| 14 | EXEL Exelixis | 3.32% | |
| 15 | INCY Incyte | 3.18% | |
| 16 | ARGX Argenx SE | 3.13% | |
| 17 | HALO Halozyme Therapeutics | 3.11% | |
| 18 | VRTX Vertex Pharmaceuticals | 3.07% | |
| 19 | RGEN Repligen | 3.07% | |
| 20 | BMRN BioMarin Pharmaceutical | 2.83% | |
| 21 | AMGN Amgen | 2.78% | |
| 22 | BNTX BioNTech SE | 2.63% | |
| 23 | GMAB Genmab A/S | 2.62% | |
| 24 | UTHR United Therapeutics Corporation | 2.56% | |
| 25 | ALNY Alnylam Pharmaceuticals | 2.52% | |
| 26 | ONC BeOne Medicines Ltd | 2.48% | |
| 27 | GILD Gilead Sciences | 2.45% | |
| 28 | ADMA ADMA Biologics | 2.33% | |
| 29 | SRPT Sarepta Therapeutics | 2.29% | |
| 30 | REGN Regeneron Pharmaceuticals | 2.25% |
FBT's holdings are from its SEC Form N-PORT for the period ended 2026-06-30, filed 2026-08-21; a newer filing replaces it when the nightly read of EDGAR finds one. Every one of the 30 positions FBT holds, with its weight, is in the fund's JSON file. See the other 54 ETFs with a page here that hold CORT, and how their weights compare with the 5.6% FBT gives it.
Category: Health Care, set by TickerInside from the ETF's own latest file. In its file of 2026-06-30, 100% of its stocks whose sector is known are health care companies, each in the sector the site gives that company. How categories are set.
https://tickerinside.com/api/v1/fund/fbt.jsonhttps://tickerinside.com/api/v1/fund/fbt.csv=IMPORTDATA("https://tickerinside.com/api/v1/fund/fbt.csv")If your sheet uses a decimal comma: =IMPORTDATA("https://tickerinside.com/api/v1/fund/fbt.csv"; ","; "en_US")curl -s https://tickerinside.com/api/v1/fund/fbt.jsonHow is FBT split by sector and country?
| Sector | Weight | Weight bar |
|---|---|---|
| Health care | 100.0% |
| Country | Weight | Weight bar |
|---|---|---|
| United States | 91.6% | |
| Belgium | 3.1% | |
| Germany | 2.6% | |
| Denmark | 2.6% |
From its SEC Form N-PORT for the period ended 2026-06-30, filed 2026-08-21. How these are measured.
What did FBT hold in its SEC reports since 2019?
In FBT's SEC filings, its largest position went from ACADIA Pharmaceuticals Inc. (ACAD) at 5.17% on 2019-09-30 to Corcept Therapeutics Incorporated (CORT) at 5.60% on 2026-06-30, across 28 quarterly reports.
| Report | Positions | Largest | Top 10 |
|---|---|---|---|
| 2019-09-30 | 29 | ACAD 5.17% | 39.8% |
| 2019-12-31 | 29 | ICPT 5.36% | 38.9% |
| 2020-12-31 | 29 | RARE 4.79% | 40.1% |
| 2021-12-31 | 29 | ACAD 4.54% | 39.1% |
| 2022-12-30 | 29 | EXAS 4.45% | 37.9% |
| 2023-12-31 | 30 | RARE 4.23% | 37.6% |
| 2024-12-31 | 30 | EXEL 4.37% | 39.3% |
| 2025-12-31 | 30 | EXAS 5.15% | 39.8% |
| 2026-06-30 | 30 | CORT 5.60% | 43.2% |
The first report, then the last of each year, of the 28 reports FBT filed on SEC Form N-PORT from 2019-09-30 to 2026-06-30, each company under its ticker today. Every position of every report is in its quarterly file, and at any date at /api/v1/history/fbt/{date}.json. How these are read.
What does FBT duplicate?
The ETF nearest to FBT is PBE: the two hold 45.2% of their weight in common, in the 16 companies both own, and 50.6% of FBT itself is also held there. Owning FBT alongside the ETFs at the top of this table means about half of the weight is held twice.
| ETF | Overlap by weight | Of FBT held there | Of that ETF in FBT | Companies in both | Overlap bar |
|---|---|---|---|---|---|
| PBE | 45.2% | 50.6% | 61.0% | 16 | |
| IBB | 41.0% | 89.3% | 60.8% | 28 | |
| BBH | 41.0% | 47.9% | 78.9% | 16 | |
| IBBQ | 30.4% | 74.7% | 49.8% | 24 | |
| GNOM | 27.7% | 37.2% | 32.3% | 11 | |
| XBI | 26.1% | 60.0% | 26.1% | 19 | |
| BMED | 23.7% | 43.1% | 28.9% | 13 | |
| IBRN | 16.6% | 16.6% | 21.2% | 5 | |
| PJP | 16.3% | 19.0% | 23.9% | 6 | |
| PTH | 14.4% | 24.9% | 14.4% | 6 | |
| IDNA | 14.3% | 14.4% | 16.0% | 5 | |
| RSPH | 13.1% | 24.5% | 13.1% | 8 |
FBT's holdings are from its SEC Form N-PORT for the period ended 2026-06-30, filed 2026-08-21. BBH's holdings are from its SEC Form N-PORT for the period ended 2026-06-30, filed 2026-08-26. The other ETFs' holdings are from their issuers' latest files. Check FBT against any ETF in the ETF overlap calculator · how overlap is measured.
What adds something different to FBT?
SOXX shares 0% of weight with FBT. The table lists the covered ETFs with the least in common with FBT, least shared weight first.
| ETF | Name | Overlap by weight | Companies in both |
|---|---|---|---|
| SOXX | iShares Semiconductor ETF | 0.0% | 0 |
| SCZ | iShares MSCI EAFE Small-Cap ETF | 0.0% | 0 |
| PFF | iShares Preferred and Income Securities ETF | 0.0% | 0 |
| MCHI | iShares MSCI China ETF | 0.0% | 0 |
| REET | iShares Global REIT ETF | 0.0% | 0 |
| USRT | iShares Core U.S. REIT ETF | 0.0% | 0 |
| IYR | iShares U.S. Real Estate ETF | 0.0% | 0 |
| PICK | iShares MSCI Global Metals & Mining Producers ETF | 0.0% | 0 |
FBT's holdings are from its SEC Form N-PORT for the period ended 2026-06-30, filed 2026-08-21. The other ETFs' holdings are from their issuers' latest files.
Cost and concentration
| Expense ratio | 0.55% |
|---|---|
| Weight in the ten largest positions | 43.2% |
| Largest single position | 5.6% |
The expense ratio is reference data, from FBT's SEC filing of 2026-04-30; the weights are from FBT's SEC Form N-PORT for the period ended 2026-06-30.
Where to go next
- FMED, Fidelity Disruptive Medicine ETF
- GNOM, Global X Genomics & Biotechnology ETF
- IBB, iShares Biotechnology ETF
- IBBQ, Invesco Nasdaq Biotechnology ETF
- Run a portfolio x-ray to see what FBT carries once you look through it
- Compare FBT against any other ETF in the builder
Holdings from FBT's SEC Form N-PORT for the period ended 2026-06-30, filed 2026-08-21. How every figure here is produced. Measurements, not investment advice.
Cite this page
TickerInside, First Trust NYSE Arca Biotechnology Index Fund (FBT), holdings from SEC Form N-PORT for the period ended 2026-06-30, filed 2026-08-21, https://tickerinside.com/etf/fbt/, CC BY 4.0
<a href="https://tickerinside.com/etf/fbt/">TickerInside</a> (https://tickerinside.com/etf/fbt/)